Target intelligence / Profile preview

Pain-related ion channels

Molecular classification
Ion channel [1.1.1], Receptor [1.3.1]
01

Overview

Pain-related ion channels represent a broad class of membrane proteins essential for the transduction, conduction, and transmission of nociceptive signals in the peripheral and central nervous systems [1.2.1, 1.2.3]. This group encompasses several families, including voltage-gated sodium channels (e.g., Nav1.7, Nav1.8), voltage-gated calcium channels (e.g., Cav2.2), transient receptor potential (TRP) channels (e.g., TRPV1), and ligand-gated channels like P2X3 receptors [1.1.2, 1.3.1]. These channels are responsible for converting mechanical, thermal, or chemical stimuli into electrical impulses and regulating the excitability of sensory neurons [1.2.5, 1.3.2]. In pathological states, such as nerve injury or chronic inflammation, the expression and function of these channels are often dysregulated, leading to neuronal hyperexcitability and persistent pain [1.2.3, 1.2.4]. Therapeutic strategies targeting these channels aim to restore normal signaling or block the transmission of pain, with examples ranging from traditional local anesthetics like lidocaine to more selective modern agents like Nav1.8 inhibitors and P2X3 antagonists [1.1.1, 1.3.3].

Other names
Nociceptive ion channelsPain-associated ion channelsSensory ion channelsIon channels in pain signaling
02

Mechanism of action

Modulation of ion flow through selective or non-selective inhibition or activation of channels to reduce neuronal excitability and pain signal transmission [1.1.1, 1.3.1].

03

Biological functions

Signal transduction [1.2.1]Nociception [1.2.3]Sensory perception [1.3.1]Electrogenesis [1.3.2]Neurotransmitter release [1.2.5]
04

Disease associations

Chronic pain [1.2.3]Neuropathic pain [1.2.4]Inflammatory pain [1.2.2]Erythromelalgia [1.1.2]Congenital insensitivity to pain [1.1.2]
05

Safety considerations

Off-target cardiac toxicity [1.1.1]Central nervous system side effects such as dizziness and somnolence [1.3.3]Hyperthermia associated with TRPV1 antagonists [1.1.4]Narrow therapeutic index for non-selective blockers [1.1.1]
06

Interacting drugs

Lidocaine [1.1.1]

8 more in the full profile.

07

Biomarkers

SCN9A genetic mutations [1.1.2]Quantitative sensory testing (QST) [1.3.2]Nerve conduction studies [1.2.4]

Beyond the preview

Go deeper on Pain-related ion channels.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pain-related ion channels.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call